Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials

Ophthalmology

Volumn 120, Issue 9, 2013, Pages 1860-1870

  Jaffe, Glenn J ^a   Martin, Daniel F ^b   Toth, Cynthia A ^a   Daniel, Ebenezer ^c   Maguire, Maureen G ^c   Ying, Gui Shuang ^c   Grunwald, Juan E ^c   Huang, Jiayan ^c  

^a DUKE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

ADULT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MORPHOLOGY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINAL THICKNESS; TREATMENT DURATION; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; PROSPECTIVE STUDIES; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84883806471     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.01.073     Document Type: Conference Paper

References (13)

1. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
2. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and S.L. Fine Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
3. CATT Research Group D.F. Martin, M.G. Maguire, and G.S. Ying Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
4. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
5. F.C. Decroos, C.A. Toth, and S.S. Stinnett Optical coherence tomography grading reproducibility during the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology 119 2012 2549 2557
6. G.S. Ying, J. Huang, M.G. Maguire Comparison of Age-related Macular Degeneration Treatments Trials Research Group Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ophthalmology 120 2013 122 129
7. J.E. Grunwald, E. Daniel, G.S. Ying CATT Research Group Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology 119 2012 1634 1641
8. R.W. Beck, P.S. Moke, and A.H. Turpin A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol Am J Ophthalmol 135 2003 194 205
9. A. Chan, J.S. Duker, and T.H. Ko Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography Arch Ophthalmol 124 2006 193 198
10. W.S. Cleveland Robust locally weighted regression and smoothing scatterplots J Am Stat Assoc 74 1979 829 836
11. T.D. Ting, M. Oh, and T.A. Cox Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration Arch Ophthalmol 120 2002 731 737
12. M.A. Gamulescu, V. Radeck, and B. Lustinger Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration Int Ophthalmol 30 2010 261 266
13. P.K. Kaiser, B.A. Blodi, H. Shapiro, N.R. Acharya MARINA Study Group Angiographic and optical coherence tomographic results of the MARINA Study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2007 1868 1875